A federal judge dismissed a lawsuit that sought to block a California law requiring drug makers to not only provide advance notice of price hikes, but also give the reasons for any increases.

In explaining his decision, U.S. District Judge Morrison England Jr. ruled that the Pharmaceutical Research and Manufacturers of America failed to show that the court has jurisdiction to hear the case. However, he wrote that the trade group can refile its case if it can prove that any potential harm to drug makers falls “outside the realm of conjecture,” a step that would give PhRMA standing to press it case.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy